[7] [8] Patients should contact their healthcare provider immediately if they experience persistent vomiting, inability to maintain hydration, severe or persistent abdominal pain (which could indicate pancreatitis, a rare but serious side effect), bilious vomiting, signs of wound complications, or inability to keep fluids down
This is a common question amongst patients considering prescription weight-loss treatments
This condition has been observed to have a familial tendency (16)
MHRA-licensed alternatives for weight management in the UK include semaglutide (Wegovy), liraglutide (Saxenda), tirzepatide (Mounjaro), and orlistat
No insurance is required, no membership fees apply, and shipping to Canada is available, making it a transparent, accessible option for cross-border patients